Download PDFPDF

5PSQ-049 Palbociclib in metastatic breast cancer treatment: real life toxicity and frequency of dose reduction or permanent discontinuation
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address